Cargando…

High-capacity assay to quantify the clonal heterogeneity in potency of mesenchymal stem cells

Detalles Bibliográficos
Autores principales:	O’Connor, Kim C, Russell, Katie C, Phinney, Donald G, Lacey, Michelle R, Barrilleaux, Bonnie L, Meyertholen, Kristin E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284945/ https://www.ncbi.nlm.nih.gov/pubmed/22373225 http://dx.doi.org/10.1186/1753-6561-5-S8-O14

Ejemplares similares

ADCC potency assay: increased standardization with modified lymphocytes
por: Bretaudeau, Laurent, et al.
Publicado: (2011)

Intratumoral heterogeneity and clonal evolution in blood malignancies and solid tumors
por: Varela, Ignacio, et al.
Publicado: (2017)

Transduction of Human Cells with Polymer-complexed Ecotropic Lentivirus for Enhanced Biosafety
por: Barrilleaux, Bonnie, et al.
Publicado: (2011)

Mesenchymal stem cells from cortical bone demonstrate increased clonal incidence, potency, and developmental capacity compared to their bone marrow–derived counterparts
por: Blashki, Daniel, et al.
Publicado: (2016)

HTLV-1 clonality during chronic infection and BLV clonality during primary infection
por: Gillet, Nicolas A, et al.
Publicado: (2011)

The standardized mistletoe preparation Lektinol has antitumoral potencies
por: Mengs, U, et al.
Publicado: (2001)

Assaying the Potency of Influenza Vaccines
por: Minor, Philip D.
Publicado: (2015)

Chemokine Assay Matrix Defines the Potency of Human Bone Marrow Mesenchymal Stromal Cells
por: Lipat, Ariel Joy, et al.
Publicado: (2022)

Quantifying genetic effects on disease mediated by assayed gene expression levels
por: Yao, Douglas W., et al.
Publicado: (2020)

Optimizing an immunomodulatory potency assay for Mesenchymal Stromal Cell
por: Hansen, Stine Bangsgaard, et al.
Publicado: (2022)

A neuraminidase potency assay for quantitative assessment of neuraminidase in influenza vaccines
por: Byrne-Nash, Rose T., et al.
Publicado: (2019)

VaxArray potency assay for rapid assessment of “pandemic” influenza vaccines
por: Byrne-Nash, Rose T., et al.
Publicado: (2018)

HTLV-1 persistence in vivo: clonality, dynamics and immune response
por: M Bangham, Charles R, et al.
Publicado: (2011)

Confronting the next pandemic—Workshop on lessons learned from potency testing of pandemic (H1N1) 2009 influenza vaccines and considerations for future potency tests, Ottawa, Canada, July 27–29, 2010
por: Hardy, Stephanie, et al.
Publicado: (2011)

Quantifying Clonal and Subclonal Passenger Mutations in Cancer Evolution
por: Bozic, Ivana, et al.
Publicado: (2016)

Bananas decrease acetaminophen potency in in vitro assays
por: Uesawa, Yoshihiro, et al.
Publicado: (2018)

Distinct antithrombin III preparations deactivate IL-8-induced neutrophil chemotaxis with different potency
por: Kaneider, N, et al.
Publicado: (2001)

Biological and Clinical Implications of Clonal Heterogeneity and Clonal Evolution in Multiple Myeloma
por: Bianchi, Giada, et al.
Publicado: (2014)

Relative potency of xenobiotic estrogens in an acute in vivo mammalian assay.
por: Milligan, S R, et al.
Publicado: (1998)

Intratumoral heterogeneity and clonal evolution in liver cancer
por: Losic, Bojan, et al.
Publicado: (2020)

Genetic heterogeneity and clonal evolution in neuroblastoma
por: Mora, J, et al.
Publicado: (2001)

Modeling the clonal heterogeneity of stem cells
por: Tuck, David P, et al.
Publicado: (2010)

Synovial B Cells in Rheumatoid Arthritis: Clonal Expansion, Diversification, and Persistence
por: Chiorazzi, Nicholas, et al.
Publicado: (2000)

Comparison of potency assays to assess SARS-CoV-2 neutralizing antibody capacity in COVID-19 convalescent plasma
por: von Rhein, Christine, et al.
Publicado: (2021)

BrainView: a software designed for quantifying brain volume, weight and density
por: Lescot, T, et al.
Publicado: (2003)

Potency Assays for Mesenchymal Stromal Cell Secretome-Based Products for Tissue Regeneration
por: Sagaradze, Georgy, et al.
Publicado: (2023)

Decreased potency of fimasartan in liver cirrhosis was quantified using mixed-effects analysis
por: Kim, Choon OK, et al.
Publicado: (2017)

A robust potency assay highlights significant donor variation of human mesenchymal stem/progenitor cell immune modulatory capacity and extended radio-resistance
por: Ketterl, Nina, et al.
Publicado: (2015)

Quantifiable Metrics for Predicting MSC Therapeutic Efficacy
por: Boregowda, Siddaraju V, et al.
Publicado: (2016)

Summary Report of a Meeting on the Estimation of the Potency of Inactivated Poliovaccine: Institut Pasteur, Paris 12–13 February 1990
por: Minor, Philip
Publicado: (1990)

Clonal evolution in a patient with CML detected by FISH precedes imatinib treatment failure
por: Enriquez, Virginia, et al.
Publicado: (2007)

Digital Image Analysis to Quantify Inflammation in Synovial Tissue
por: Andersson, Ulf
Publicado: (2000)

Functions of Heterogeneous Nuclear Ribonucleoproteins in Stem Cell Potency and Differentiation
por: Chen, Qishan, et al.
Publicado: (2013)

Heterogeneity and Potency of Peripheral Glial Cells in Embryonic Development and Adults
por: Sinegubov, Artem, et al.
Publicado: (2022)

The role of clonal communication and heterogeneity in breast cancer
por: Martín-Pardillos, Ana, et al.
Publicado: (2019)

The clonal heterogeneity of colon cancer with liver metastases
por: Chen, Guanxuan, et al.
Publicado: (2023)

Quantifying tumour heterogeneity with CT
por: Ganeshan, Balaji, et al.
Publicado: (2013)

Methods for quantifying the heterogeneity of psychopathology
por: Buss, John F., et al.
Publicado: (2023)

Surrogate potency assays: Comparison of binding profiles complements dose response curves for unambiguous assessment of relative potencies
por: Karlsson, Robert, et al.
Publicado: (2018)

A 10-year review of lymphoma detected by breast screening
por: O'Connor, A, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_lm2d7jre09ckf0v56ivv6f0d4a